Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
暂无分享,去创建一个
Deborah Schrag | Ahmedin Jemal | Elizabeth Ward | A. Jemal | Elizabeth E Ward | L. Pickle | P. Wingo | L. Ries | B. Edwards | R. Anderson | H. Howe | J. Warren | P. Jamison | D. Schrag | Martin L. Brown | L. Harlan | Xiao-Cheng Wu | Lynn A G Ries | Brenda K Edwards | Martin L Brown | Phyllis A Wingo | Patricia M Jamison | Robert N Anderson | X. C. Wu | C. Friedman | Xiao Cheng Wu | Holly L Howe | Linda W Pickle | Carol Friedman | Linda Harlan | Joan Warren | Elizabeth E. Ward | Robert N. Anderson
[1] A. Zaslavsky,et al. Completeness of Information on Adjuvant Therapies for Colorectal Cancer in Population-Based Cancer Registries , 2003, Medical care.
[2] C. Somkin,et al. Cost of Care for Cancer in a Health Maintenance Organization , 1997, Health care financing review.
[3] S. Edge,et al. Treatment of early-stage breast cancer. , 1999, Current problems in cancer.
[4] M. Thun,et al. Tobacco use and cancer: an epidemiologic perspective for geneticists , 2002, Oncogene.
[5] C. Lynch,et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Daniel S. Miller,et al. Cancer incidence and mortality, 1973‐1995 , 1998 .
[7] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.
[8] Gregory S. Cooper,et al. Studying Radiation Therapy Using SEER-Medicare-Linked Data , 2002, Medical care.
[9] A. Neugut,et al. Survival Associated with 5-FluorouracilBased Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer , 2002, Annals of Internal Medicine.
[10] W. Barlow,et al. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients. , 1999, Health services research.
[11] E. Perez-stable,et al. Epidemiology of cancer among Hispanics in the United States. , 1995, Journal of the National Cancer Institute. Monographs.
[12] Daniel S. Miller,et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.
[13] Joseph V. Simone,et al. Ensuring Quality Cancer Care , 1999 .
[14] L. Bernstein,et al. Rapidly rising breast cancer incidence rates among Asian‐American women , 2002, International journal of cancer.
[15] G. Cooper,et al. Use of SEER-Medicare Data for Measuring Cancer Surgery , 2002, Medical care.
[16] M. Symons,et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. , 2003, Journal of the National Cancer Institute.
[17] M. Weinstein,et al. Who gets chemotherapy for metastatic lung cancer? , 2000, Chest.
[18] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. , 2003, Journal of the National Cancer Institute.
[19] Katherine L Kahn,et al. Validity of cancer registry data for measuring the quality of breast cancer care. , 2002, Journal of the National Cancer Institute.
[20] Peter H Gann,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.
[21] E. Feuer,et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. , 2001, Gastrointestinal endoscopy.
[22] J. Stanford,et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. , 1999, Journal of the National Cancer Institute.
[23] Michael J Thun,et al. Long‐term trends in cancer mortality in the United States, 1930–1998 , 2003, Cancer.
[24] Joseph V. Simone,et al. Enhancing Data Systems to Improve the Quality of Cancer Care , 2000 .
[25] W. Pe,et al. Cancer incidence in New York City Hispanics, 1982 to 1985. , 1991 .
[26] C. Erlichman. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.
[28] T R Fleming,et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.
[29] A. Jemal,et al. Recent trends in lung cancer mortality in the United States. , 2001, Journal of the National Cancer Institute.
[30] H M Rosenberg,et al. Age standardization of death rates: implementation of the year 2000 standard. , 1998, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[31] L. Kessler,et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. , 1996, Journal of the National Cancer Institute.
[32] V. Shavers,et al. Race/Ethnicity and the Intensity of Medical Monitoring Under ‘Watchful Waiting’ for Prostate Cancer , 2004, Medical care.
[33] C. Begg,et al. Impact of hospital volume on operative mortality for major cancer surgery. , 1998, JAMA.
[34] B. Hankey,et al. The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[35] K. Kahn,et al. Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Deborah Schrag,et al. Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.
[37] A. Neugut,et al. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. , 2001, Cancer journal.
[38] S. Edge,et al. Measuring and Predicting Surgeons’ Practice Styles for Breast Cancer Treatment in Older Women , 2001, Medical care.
[39] K. Kerlikowske,et al. Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.
[40] M. Weinstein,et al. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] C. Begg,et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection , 2003, Journal of surgical oncology.
[42] Colin B Begg,et al. Variations in morbidity after radical prostatectomy. , 2002, The New England journal of medicine.
[43] L. Kessler,et al. Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis , 1995, Medical care.
[44] A. Jemal,et al. Contemporary Lung Cancer Trends among U.S. Women , 2005, Cancer Epidemiology Biomarkers & Prevention.
[45] K. Kerlikowske,et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.
[46] C. Klabunde,et al. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. , 1999, JAMA.
[47] Thomas J. Smith,et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] O. Brawley,et al. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] B. Edwards,et al. A vision for cancer incidence surveillance in the United States , 2003, Cancer Causes & Control.
[50] Ahmedin Jemal,et al. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.
[51] C. Earle,et al. Trends in the aggressiveness of cancer care near the end of life. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] M. Fay,et al. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] J. Fraumeni,et al. Declining lung cancer rates among young men and women in the United States: a cohort analysis. , 1989, Journal of the National Cancer Institute.
[54] C B Begg,et al. Racial differences in the treatment of early-stage lung cancer. , 1999, The New England journal of medicine.
[55] J. Warren,et al. Can cancer registry data be used to study cancer treatment? , 2003, Medical care.
[56] J. Stanford,et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. , 2004, Journal of the National Cancer Institute.
[57] A. Neugut,et al. Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study. , 2004, Gynecologic oncology.
[58] V. Shavers,et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer , 2004, Journal of General Internal Medicine.
[59] C. Muir,et al. International Classification of Diseases for Oncology , 1990 .
[60] Hyune-Ju Kim,et al. Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .
[61] R D Etzioni,et al. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. , 1999, Medical care.
[62] K. Kerlikowske,et al. Is there a downside to elderly women undergoing screening mammography? , 1998, Journal of the National Cancer Institute.
[63] J L Freeman,et al. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. , 2000, Medical care.
[64] W. Barlow,et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. , 1997, Journal of the National Cancer Institute.
[65] W. Barlow,et al. Survival and Treatment for Colorectal Cancer Medicare Patients in Two Group/Staff Health Maintenance Organizations and the Fee-for-Service Setting , 1999, Medical care research and review : MCRR.
[66] E. Trimble,et al. The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up. , 1994, Gynecologic oncology.
[67] B. Smedley,et al. The unequal burden of cancer : an assessment of NIH research and programs for ethnic minorities and the medically underserved , 1999 .
[68] Daniel S. Miller,et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.
[69] D. Buist,et al. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. , 2001, Journal of the National Cancer Institute.
[70] K. Kahn,et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] M. McMillen,et al. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates. , 1992, Journal of the National Cancer Institute.
[72] Ruth Etzioni,et al. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. , 2004, Urology.
[73] T. Fleming,et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] M. Barry,et al. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. , 1996, Journal of the National Cancer Institute.
[75] E. Feuer,et al. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States , 1998, Cancer Causes & Control.
[76] R A Stephenson,et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.
[77] K. Thorpe,et al. Health insurance and spending among cancer patients. , 2003, Health affairs.
[78] C. Begg,et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] A. Neugut,et al. Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. , 2004, Gynecologic oncology.
[80] J. Meyerhardt,et al. Association of Hospital Procedure Volume and Outcomes in Patients with Colon Cancer at High Risk for Recurrence , 2003, Annals of Internal Medicine.
[81] C. Begg,et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.
[82] A. Zaslavsky,et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] Ruth Etzioni,et al. Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data , 2002, Medical care.
[84] L. Clegg,et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[85] J. Mclaughlin,et al. Comparability of the death certificate and the 1986 National Mortality Followback Survey. , 1993, Vital and health statistics. Series 2, Data evaluation and methods research.
[86] H M Rosenberg,et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.
[87] E. Feuer,et al. Impact of reporting delay and reporting error on cancer incidence rates and trends. , 2002, Journal of the National Cancer Institute.
[88] A. Donabedian. Evaluating the quality of medical care. 1966. , 1966, The Milbank quarterly.
[89] N Urban,et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. , 1995, Journal of the National Cancer Institute.
[90] E. Trimble,et al. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[91] J R Sugarman,et al. Improving American Indian cancer data in the Washington State Cancer Registry using linkages with the Indian Health Service and tribal records , 1996, Cancer.
[92] E. Feuer,et al. Confidence intervals for directly standardized rates: a method based on the gamma distribution. , 1997, Statistics in medicine.
[93] Robert B Wallace,et al. Population variations in the initial treatment of non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[94] A. Neugut,et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] A. Neugut,et al. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] G. A. Alexander,et al. Racial/ethnic patterns of cancer in the United States, 1988-1992. , 1996 .
[97] H M Rosenberg,et al. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[98] Robert J. Mayer,et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.
[99] M. Thun,et al. A national framework for cancer surveillance in the United States , 2005, Cancer Causes & Control.
[100] M. Weinstein,et al. Impact of referral patterns on the use of chemotherapy for lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[101] Klein Rj,et al. Age adjustment using the 2000 projected U.S. population. , 2001 .
[102] N. Cobb,et al. Cancer mortality among American Indians and Alaska Natives: regional differences, 1994-1998. , 2003 .
[103] Colin B Begg,et al. Adherence to surveillance among patients with superficial bladder cancer. , 2003, Journal of the National Cancer Institute.
[104] P. Sorlie,et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. , 1999, Vital and health statistics. Series 2, Data evaluation and methods research.
[105] D. Doering,et al. Cervical cancer in Kentucky. , 2000, The Journal of the Kentucky Medical Association.
[106] J. Stanford,et al. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[107] E. Gilpin,et al. Smoking initiation by adolescent girls, 1944 through 1988. An association with targeted advertising. , 1994, JAMA.
[108] E. Partridge,et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer , 1996, New England Journal of Medicine.
[109] D A Carr,et al. Two new templates for epidemiology applications: linked micromap plots and conditioned choropleth maps. , 2000, Statistics in medicine.
[110] J. Stanford,et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. , 2001, Journal of the National Cancer Institute.
[111] C. Begg,et al. Hospital and Surgeon Procedure Volume as Predictors of Outcome Following Rectal Cancer Resection , 2002, Annals of surgery.
[112] B. Kramer,et al. Trends and black/white differences in treatment for nonmetastatic prostate cancer. , 1998, Medical care.
[113] C. Begg,et al. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[114] C. Begg,et al. The Effect of Clustering of Outcomes on the Association of Procedure Volume and Surgical Outcomes , 2003, Annals of Internal Medicine.
[115] E. Emanuel,et al. Patterns of care studies: creating "an environment of watchful concern". , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[116] L. Kessler,et al. Potential for Cancer Related Health Services Research Using a Linked Medicare‐Tumor Registry Database , 1993, Medical care.